References
- Jabs DA, Rosenbaum JT, Foster S, et al. Guidelines for the use of ımmunosuppressive drugs in patients with ocular inflammatory disorders: Recommendations of an expert panel. Am J Ophthalmol 2000;130(4):492–513
- Evereklioglu C. Ocular Behçet disease: Current therapeutic approaches. Curr Opin Ophthalmol 2011;22(6):508–516
- Evereklioglu C. Current concepts in the etiology and treatment of Behçet disease. Surv Ophthalmol 2005;50(4):297–350
- Kitaichi N, Miyazaki A, Stanford MR, et al. Ocular features of Behçet’s disease: An international colloborative study. Br J Ophthalmol 2007;91(12):1579–1582
- Sakane T, Takeno M, Suzuki N, Inaba G. Behçet’s disease. N Engl J Med 1999;341(17):1284–1291
- Trinh L, Brignole-Baudouin F, Labbe A, et al. The corneal endothelium in an endotoxin-induced uveitis model: Correlation between in vivo confocal microscopy and immunohistochemistry. Mol Vis 2008;14:1149–1156
- Taylor SR, Singh J, Menezo V, et al. Behçet Disease: Visual prognosis and factors influencing the development of visual loss. Am J Ophthalmol 2011;152(6):1059–1066
- Kotecha A. What biomechanical properties of the cornea are relevant for the clinician? Surv Ophthalmol 2007;52:109–114
- Shah S, Laiquzzaman M, Cunliffe I, Mantry S. The use of the Reichert ocular response analyser to establish the relationship between ocular hysteresis, corneal resistance factor and central corneal thickness in normal eyes. Cont Lens Anterior Eye 2006; 29(5):257–262
- Oliveira F, Motta ACO, Muccioli C. Corneal specular microscopy in infectious and noninfectious uveitis. Arq Bras Oftalmol 2009;72:457–461
- Faramarzi A, Soheilian M, Jabbarpoor Bonyadi MH, Yaseri M. Corneal astigmatism in unilateral Fuchs heterochromic iridocyclitis. Ocul Immunol Inflamm 2011;19(3):151–155
- Muller LJ, Pels E, Vrensen GF. The specific architecture of the anterior stroma accounts for the maintenance of corneal curvature. Br J Ophthalmol 2001;85(4):437–443
- Pepose JS, Feigenbaum SK, Qazi MA, et al. Changes in corneal biomechanics and intraocular pressure following LASIK using static, dynamic, and noncontact tonometry. Am J Ophthalmol 2007;143(1):39–47
- Emre S, Kayikcioglu O, Ates H, et al. Corneal hysteresis, corneal resistance factor, and intraocular pressure measurement in patients with scleroderma using the reichert ocular response analyzer. Cornea 2010;29(6):628–631
- Ahn JK, Yu HG, Chung H, Park YG. Intraocular cytokine environment in active Behçet uveitis. Am J Ophthalmol 2006;142(3):429–434
- Vural ET, Acar BT, Sevim MS, et al. Corneal biomechanical properties in patients with recurrent anterior uveitis. Ocul Immunol Inflamm 2012;20(5):349–353
- Evereklioglu C, Er H. Increased corneal thickness in active Behçet’s disease. Eur J Ophthalmol 2002;12(1):24–29
- Ozdamar Y, Berker N, Ertugrul G, et al. Is there a change of corneal thickness in uveitis with Behçet disease? Cornea 2010;29(11):1265–1267
- Lam A, Chen D, Chiu R, Chiu WS. Comparison of IOP measurements between ORA and GAT in normal Chinese. Optom Vis Sci 2007;84:909–914
- Luce DA. Determining in vivo biomechanical properties of the cornea with an ocular response analyzer. J Cataract Refract Surg 2005;31(1):156–162
- Chihara E. Assessment of true intraocular pressure: The gap between theory and practical data. Surv Ophthalmol 2008;53(3):203–218
- Brubaker RF. Tonometry and corneal thickness. Arch Ophthalmol 1999;117(1):104–105
- Shah S, Laiquzzaman M, Cunliffe I, Mantry S. The use of the Reichert ocular response analyser to establish the relationship between ocular hysteresis, corneal resistance factor and central corneal thickness in normal eyes. Cont Lens Anterior Eye 2006;29(5):257–262